http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-027757-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_646acd82cfe6e936cb3079d5ea0a6c22 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N45-00 |
| filingDate | 2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b002d9b3385fa595d9532cbff08c47a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac10661c437c1c5aecdea4805946929e |
| publicationDate | 2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-027757-B1 |
| titleOfInvention | CONJUGAT FOR CONTROLLED INSULIN DELIVERY |
| abstract | A conjugate comprising an insulin molecule conjugated through a polymeric or non-polymeric framework with one or more ligands is provided, where each ligand includes a saccharide selected from the group consisting of aminoethylflucose, aminoethyltrimannoza, aminoethylbiemannose or aminoethylmannose, which is followed by after administering, after administering, after administering, after administering, after administering, after administering it, after administering it, after administering it, after administering it, after administering it, after administering it, after administering it, after administering it, will be administered after administering it. at least one pharmacokinetic or pharmacodynamic characteristics of the conjugate depend on the serum concentration of saccharide, which is glucose or alpha etilmannozu. The invention also relates to a sustained release formulation based on a conjugate of the present invention used to treat hyperglycemia, use of a conjugate of the present invention to treat diabetes. |
| priorityDate | 2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 467.